GGrantIndex
← Search

PBC 003: Phase I trial of escalating oral doses of SCH66336 in pediatric patient

$9,521M01FY2004RRNIH

University Of California San Francisco, San Francisco CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →